News
AcouSort signs agreement with Korean life science company
AcouSort has signed a cooperation agreement with another Korean life science company. The agreement concerns the evaluation of the...
Read MoreAcouSort successfully completes product development assignment for Instrumentation Laboratory
AcouSort and the world-leading medical technology company Instrumentation Laboratory Inc. (IL) have an on-going collaboration. AcouSort has now successfully...
Read MoreEquity Research Report by Analyst Group
Today, 2020-06-18, Analyst Group published an Equity research report (Aktieanalys) on AcouSort. Direct link to the report: Aktieanalys på AcouSort...
Read MoreAcouSort signs agreement with Korean life science company
AcouSort has signed a cooperation agreement with another Korean life science company. The agreement concerns the evaluation of the...
Read MoreAcouSort successfully completes product development assignment for Instrumentation Laboratory
AcouSort and the world-leading medical technology company Instrumentation Laboratory Inc. (IL) have an on-going collaboration. AcouSort has now successfully...
Read MoreAcouSort launches a directed share issue valued SEK 11.7 million to complete development of the company’s first series of OEM-manufactured modules and the production line for these
AcouSort has today decided, for strategic reasons, to carry out a directed share issue totaling SEK 11.7 million to...
Read MoreInterview with CEO
“The market for consumable and semi-consumable blood-plasma separation modules is estimated to grow significantly in the coming years as...
Read MoreAcouSort’s technology can streamline health care – rapidly increasing global interest
AcouSort’s technology uses soundwaves to separate cells and other particles in biological fluids, for example blood samples. The technology...
Read MoreAcouSort featured in Investerarbrevet
Swedish investor news letter Investerarbrevet has published an article about AcouSort, discussing our business strategy and current projects with...
Read More